WILLIAM FOSSETT: Open Payments
NPI 1851860183 · ATKINSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 35 payments from 8 companies in 2025. Trend: 2023 $738 · 2024 $732 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $298 |
| Novo Nordisk Inc | 9 | $159 |
| Lilly USA, LLC | 6 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| Abbott Laboratories | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: BREZTRI, FARXIGA, JARDIANCE, MOUNJARO, Rybelsus, Wegovy, Ozempic, FREESTYLE LIBRE 3.
Industry payments across NC — which companies pay providers there.
